Teva Pharmaceutical Industries Limited Ordinary Shares (NY:TEVA)

39.53 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries Limited Ordinary Shares

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

35 36 Next >

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗

November 23, 2022

Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...

Via Benzinga

What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus ↗

November 23, 2022

Via Benzinga

AbbVie Finalizes To Pay Around $2.4B In Settlement Against US Opioid Lawsuits ↗

November 22, 2022

Via Benzinga

Stocks Move Higher As Wall Street Eyes China Lockdowns ↗

November 22, 2022

The Dow Jones Industrial Average is up 271 points midday, while the Nasdaq Composite and S&P 500 Index are firmly higher as well.

Via Talk Markets

Teva Finalizes Nationwide Opioid Settlement Terms

November 22, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Teva Stock Sank On Thursday ↗

November 03, 2022

There were two major developments with the company, both of which involved piles of money.

Via The Motley Fool

Teva Highlights Long-Term Data From Chorea Associated-Huntington's Treatment ↗

October 18, 2022

Via Benzinga

Why Is Imago Biosciences (IMGO) Stock Up 105% Today? ↗

November 21, 2022

Imago Biosciences (IMGO) stock is rocketing higher on Monday following news that Merck (MRK) is acquiring the company for $36 per share.

Via InvestorPlace

TEVA Stock Alert: What to Know About Teva Pharmaceuticals’ New CEO ↗

November 21, 2022

Teva Pharmaceuticals (TEVA) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO.

Via InvestorPlace

Teva Announces Appointment of Richard Francis as President and CEO

November 21, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Unique Collaboration with Rimidi to Expand the Reach of its Respiratory Digital Health Platform

November 14, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Unique Collaboration with HealthSnap to Expand the Reach of its Respiratory Digital Health Platform

November 14, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday ↗

November 14, 2022

Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at...

Via Benzinga

Eli Lilly's Migraine Drug Infringed Teva's Patents, Ordered To Pay $176M ↗

November 10, 2022

A federal jury has asked Eli Lilly And Company (NYSE: LLY) to pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to determine whether its migraine drug Emgality infringed three...

Via Benzinga

Adding $100 to These 5 Stocks Would Be a Genius Move Right Now ↗

November 09, 2022

You don't need a large pile of cash to begin building wealth on Wall Street.

Via The Motley Fool

Teva to Present Latest Research from the CONNECT1 and CONNECT2 Clinical Trials at the American College of Allergy, Asthma & Immunology (ACAAI) 2022 Annual Scientific Meeting

November 07, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Why Teva Stock Stumbled Again on Friday ↗

November 04, 2022

A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.

Via The Motley Fool

Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript ↗

November 03, 2022

TEVA earnings call for the period ending September 30, 2022.

Via The Motley Fool

Teva Pharmaceutical Posts Lower Q3 Sales & Profits, Trims FY22 Revenue Outlook ↗

November 03, 2022

Via Benzinga

Recap: Teva Pharmaceutical Q3 Earnings ↗

November 03, 2022

Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Teva Reports Third Quarter 2022 Financial Results

November 03, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Clinics Across Florida, New Jersey & California Advancing Mental Health in Underserved Communities – Awarded Funding from Teva Pharmaceuticals, Direct Relief and NAFC

October 25, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Results from 3-Year Study Assessing the Safety and Tolerability of AUSTEDO® (deutetrabenazine) Tablets for the Treatment of Chorea Associated with Huntington’s Disease

October 18, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13 ↗

October 13, 2022

Reuters

Via Benzinga

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

FDA Signals Shortage For Teva Pharma's ADHD Drug Due To Manufacturing Delay ↗

October 13, 2022

The FDA said that there was a shortage of Adderall after intermittent manufacturing delays at Teva Pharmaceutical Industries Ltd (NYSE: TEVA).

Via Benzinga

Teva Under Suspicion On Practices To Stave Off Copaxone Competition ↗

October 10, 2022

The European Commission, in an interim view, says Teva Pharmaceutical Industries Ltd (NYSE: TEVA) breached European Union (EU) antitrust rules over practices delaying competition to the multiple...

Via Benzinga

Teva Reaches Agreement With Arkansas to Settle the State’s Price Fixing Claims

October 07, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva to Host Conference Call to Discuss Third Quarter 2022 Financial Results at 8 a.m. ET on November 3, 2022

October 06, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

Teva Announces Largest-Ever Trial to Collect Information from Patients and Physicians About TD, its Impact and Progression Over Time, and Evaluate Treatment-Related Outcomes

October 06, 2022

From Teva Pharmaceutical Industries Limited

Via Business Wire

< Previous 1 2

...

20 21 22 23 24 25 26 27 28

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.